Cardiovascular revascularization medicine : including molecular interventions最新文献

Editorial: MTEER in cardiogenic shock: Time to close the treatment gap? 社论：心源性休克中的 MTEER：是时候缩小治疗差距了？

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2024-05-01 DOI: 10.1016/j.carrev.2024.05.021

Elizabeth A. Grier, Adnan K. Chhatriwalla

引用次数: 0

Editorial: Characterization of radial artery perforation patterns using optical coherence tomography. 社论：利用光学相干断层扫描鉴定桡动脉穿孔模式。

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2024-05-01 DOI: 10.1016/j.carrev.2024.05.009

Daniel H. Steinberg

引用次数: 0

The Last Broken Barrier: Retrograde Radial Artery Recanalization Prior to Transradial Coronary Interventions. 最后的屏障破裂:经桡动脉介入治疗前的逆行桡动脉再通。

IF 1.7

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2021-07-01 Epub Date: 2021-01-22 DOI: 10.1016/j.carrev.2021.01.020

Jorge Sanz-Sánchez, Damiano Regazzoli, Gennaro Petriello, Pier Pasquale Leone, Bernhard Reimers, Gabriele Luigi Gasparini

引用次数: 3

In-Depth Analysis of a Case of Persistent Severe Chronic Thromboembolic Pulmonary Hypertension. 持续性重度慢性血栓栓塞性肺动脉高压1例深入分析。

IF 1.7

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2021-07-01 Epub Date: 2020-07-10 DOI: 10.1016/j.carrev.2020.07.012

Laith Ali, Amre Ghazzal, Sohab Radwan, Christopher Barnett

{"title":"In-Depth Analysis of a Case of Persistent Severe Chronic Thromboembolic Pulmonary Hypertension.","authors":"Laith Ali, Amre Ghazzal, Sohab Radwan, Christopher Barnett","doi":"10.1016/j.carrev.2020.07.012","DOIUrl":"https://doi.org/10.1016/j.carrev.2020.07.012","url":null,"abstract":"Pulmonary hypertension (PH) is a disease characterized by an increase in the pulmonary vascular resistance that typically progresses to right heart failure and death. It is classified into five groups. Management depends on the group classification. Group four PH, chronic thromboembolic pulmonary hypertension (CTEPH) is thought to be a result of acute pulmonary emboli that cause fibrosis and scarring of the pulmonary arteries with consequent obstruction. The diagnosis of CTEPH is made by identifying perfusion abnormalities on ventilation/perfusion (V/Q) scan. Other studies required for the diagnostic evaluation include transthoracic echocardiogram, right heart catheterization, NT pro-B-type natriuretic peptide and thrombophilia evaluation. Several other tests needed to exclude other causes of pulmonary hypertension include high-resolution computed tomography (HRCT), connective tissue disease evaluation, thyroid function testing, human immunodeficiency virus testing, and liver ultrasonography to exclude portal hypertension. The treatment for CTEPH is surgical pulmonary endarterectomy (PEA). In patients who are not candidates or decline PEA, pulmonary balloon angioplasty may be useful, however, further studies are required. Several pulmonary artery hypertension medications have been studied in the management of inoperable CTEPH or persistent PH following PEA including bosentan (improves hemodynamics but not exercise capacity), macitentan (improves both hemodynamics and clinical parameters), and riociguat (improves both hemodynamics and exercise capacity). However, only riociguat is approved by the Food and Drug Administration for this indication.","PeriodicalId":519492,"journal":{"name":"Cardiovascular revascularization medicine : including molecular interventions","volume":" ","pages":"212-214"},"PeriodicalIF":1.7,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.carrev.2020.07.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25386273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Use of Impella RP for Acute Right Ventricular Failure Post-Pericardiectomy. Impella RP在心包切除术后急性右心室衰竭中的应用。

IF 1.7

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2021-07-01 Epub Date: 2021-02-15 DOI: 10.1016/j.carrev.2021.02.016

María Monteagudo-Vela, Abu Farmidi, Vasileios Panoulas, Sunil K Bhudia

引用次数: 1

The "RotaTripsy Plus" Approach in a Heavily Calcified Coronary Stenosis. 冠状动脉重度钙化狭窄的“旋切+”入路治疗。

IF 1.7

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2021-07-01 Epub Date: 2021-04-24 DOI: 10.1016/j.carrev.2021.04.022

Giuseppe Giacchi, Marco Contarini, Giovanni Ruscica, Salvatore Brugaletta

引用次数: 2

Left Axillary Intra-Aortic Balloon Pump Prolapsing in the Ascending Aorta in an End-Stage Heart Failure Patient Awaiting Transplant. 等待移植的终末期心力衰竭患者升主动脉左腋主动脉内球囊泵脱垂。

IF 1.7

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2021-07-01 Epub Date: 2021-05-01 DOI: 10.1016/j.carrev.2021.04.030

Hassan Ashraf, Adam Hafeez, Garrett Ruth, Calvin Choi

引用次数: 0

How Should I Get Prepared for and Treat Rota Burr Entrapment in a Focally Underexpanded and Restenosed Stent: A Case Report. 如何准备和治疗局部扩张不足和再狭窄支架中的Rota Burr夹持:1例报告。

IF 1.7

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2021-07-01 Epub Date: 2021-05-14 DOI: 10.1016/j.carrev.2021.05.007

George Kassimis, Antonios Ziakas, Matthaios Didagelos, Konstantinos C Theodoropoulos, Stavros Hadjimiltiades

引用次数: 0

Intravascular Lithotripsy for Severe Calcium-Mediated Peripheral Vascular Stent Underexpansion. 血管内碎石术治疗严重钙介导的周围血管支架扩张不足。

IF 1.7

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2021-07-01 Epub Date: 2020-07-01 DOI: 10.1016/j.carrev.2020.06.026

Luai Tabaza, Hafeez Ul Hassan Virk, Sean Janzer, Jon C George

引用次数: 2

Angled Microcatheter Assisted Antegrade Dissection Re-Entry Technique for Tortuous Totally Occluded Coronary Arteries. 倾斜微导管辅助顺行夹层再入技术治疗迂曲的完全闭塞冠状动脉。

IF 1.7

Cardiovascular revascularization medicine : including molecular interventions Pub Date : 2021-07-01 Epub Date: 2021-01-07 DOI: 10.1016/j.carrev.2021.01.004

Waqas T Qureshi, Adedotun Anthony Ogunsua, Amartya Kundu, Yasar Sattar, Daniel Z Fisher, Nikolaos Kakouros

{"title":"Angled Microcatheter Assisted Antegrade Dissection Re-Entry Technique for Tortuous Totally Occluded Coronary Arteries.","authors":"Waqas T Qureshi, Adedotun Anthony Ogunsua, Amartya Kundu, Yasar Sattar, Daniel Z Fisher, Nikolaos Kakouros","doi":"10.1016/j.carrev.2021.01.004","DOIUrl":"https://doi.org/10.1016/j.carrev.2021.01.004","url":null,"abstract":"Background: Subacute total occlusion in the setting of a tortuous vessel can be a therapeutic challenge. we demonstrate a safe and successful approach to deploy drug eluting stent of this complex lesion by using angled microcatheter.Case presentation: A 61-year-old male with multiple atherosclerotic risk factors diagnosed with NSTEMI secondary to subacute total occlusion of the mid right coronary artery (RCA) with collaterals filling from septal perforators arising from mid left anterior descending artery. Due to severe tortuosity of RCA, the wire inside of Corsair microcatheter kept directing away from the lumen. Therefore, Corsair was exchanged for 90-degree SuperCross™ angled microcatheter that was rotated to direct its opening towards the lumen. A Confianza pro 12 wire was used to puncture into the lumen from the subinitimal position. SuperCross™ microcatheter was advanced over the wire into the lumen and eventually drug eluting stents were deployed successfully.Conclusion: While facing subacute total occlusion with proximal end in a tortuous artery, SuperCross™ microcatheter assisted dissection reentry could be attempted after failure of antegrade wire escalation technique.Learning objective: Facilitate the use of SuperCross™ microcatheter assisted dissection reentry as a successful approach for subacute total occlusion in tortuous vessels.","PeriodicalId":519492,"journal":{"name":"Cardiovascular revascularization medicine : including molecular interventions","volume":" ","pages":"127-131"},"PeriodicalIF":1.7,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.carrev.2021.01.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38869288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2